Filing Details
- Accession Number:
- 0001209191-19-056456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-13 17:51:14
- Reporting Period:
- 2019-11-11
- Accepted Time:
- 2019-11-13 17:51:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1763897 | Paul Mcclintock | 7475 Lusk Blvd. San Diego CA 92121 | President, U.s. Commercial | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-11-11 | 3,314 | $72.04 | 400 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Weighted average sales price from sales transactions ranging from $71.90 to $72.08. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.